Related references
Note: Only part of the references are listed.Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension? A Systematic Review and Meta-Analysis
Muhammad Shahzeb Khan et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil
Mona Ascha et al.
CARDIOVASCULAR THERAPEUTICS (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
Ioana R. Preston et al.
CIRCULATION (2015)
Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension
Byung Ju Kang et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study
Andrew Goudie et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis
Daniel Caldeira et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Anticoagulation and Survival in Pulmonary Arterial Hypertension Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)
Karen M. Olsson et al.
CIRCULATION (2014)
Formal Synthesis of Antiplatelet Drug, Beraprost
Naredla Kesava Reddy et al.
ORGANIC LETTERS (2012)
Antiplatelet Drugs - Do We Need New Options? With a Reappraisal of Direct Thromboxane Inhibitors
Sergio Coccheri
DRUGS (2010)
The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists
Ian Adatia et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
An epidemiological study of pulmonary arterial hypertension
A. J. Peacock et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Changing the prognosis of pulmonary arterial hypertension: impact of medical therapy
MM Chakinala
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Methodological index for non-randomized studies (MINORS):: Development and validation of a new instrument
K Slim et al.
ANZ JOURNAL OF SURGERY (2003)
Prognosis in patients with primary pulmonary hypertension awaiting lung transplantation
R Ewert et al.
TRANSPLANTATION PROCEEDINGS (2001)
Pathobiology of pulmonary hypertension - The role of platelets and thrombosis
P Herve et al.
CLINICS IN CHEST MEDICINE (2001)